Clinical trial
Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute…
NCT00003729 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Terminated
Key facts
| NCT number | NCT00003729 |
|---|---|
| Title | Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia |
| Official title | Phase II Study of Fludarabine + Idarubicin + Aracytine in Refractory or Relapsed ALL in Children |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | cytarabine, fludarabine phosphate, idarubicin |
| Enrollment | 13 |
| Start date | Dec 1, 1998 |
| Primary completion | Apr 1, 2002 |
| First posted | Dec 10, 2003 |
| Last update posted | Sep 24, 2012 |
| Countries | Belgium, France, Portugal |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: